Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Pilar Garrido(Instituto Cajal), Fernando López‐Ríos(Hospital Universitario HM Sanchinarro)

Clinical & Translational Oncology

October 9, 2019

10.1007/s12094-019-02218-4

Cited by 104

Related Papers

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry

|PLoS ONE|2012|107

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

|Journal of Thoracic Oncology|2019|71